nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—melanoma	0.697	1	CbGaD
Oxaprozin—PTGS2—leg—melanoma	0.00258	0.162	CbGeAlD
Oxaprozin—PTGS2—hindlimb—melanoma	0.0023	0.145	CbGeAlD
Oxaprozin—PTGS2—appendage—melanoma	0.00197	0.124	CbGeAlD
Oxaprozin—Bifonazole—CYP17A1—melanoma	0.00174	0.358	CrCbGaD
Oxaprozin—PTGS2—skin epidermis—melanoma	0.00164	0.104	CbGeAlD
Oxaprozin—Deafness—Temozolomide—melanoma	0.00135	0.00602	CcSEcCtD
Oxaprozin—Vascular purpura—Temozolomide—melanoma	0.00135	0.00602	CcSEcCtD
Oxaprozin—Hepatic failure—Temozolomide—melanoma	0.00135	0.00599	CcSEcCtD
Oxaprozin—Dermatitis exfoliative—Temozolomide—melanoma	0.00128	0.00571	CcSEcCtD
Oxaprozin—Purpura—Temozolomide—melanoma	0.00125	0.00559	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00125	0.00557	CcSEcCtD
Oxaprozin—PTGS1—endothelium—melanoma	0.00125	0.0786	CbGeAlD
Oxaprozin—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.0012	0.00536	CcSEcCtD
Oxaprozin—Oliguria—Docetaxel—melanoma	0.0012	0.00536	CcSEcCtD
Oxaprozin—PTGS2—endothelium—melanoma	0.00119	0.0751	CbGeAlD
Oxaprozin—Pancytopenia—Bleomycin—melanoma	0.00118	0.00524	CcSEcCtD
Oxaprozin—Hearing impaired—Docetaxel—melanoma	0.00116	0.00518	CcSEcCtD
Oxaprozin—Anaphylactic shock—Vemurafenib—melanoma	0.00116	0.00518	CcSEcCtD
Oxaprozin—Infection—Vemurafenib—melanoma	0.00116	0.00515	CcSEcCtD
Oxaprozin—PTGS1—blood vessel—melanoma	0.00115	0.0725	CbGeAlD
Oxaprozin—Pneumonia—Bleomycin—melanoma	0.00111	0.00495	CcSEcCtD
Oxaprozin—PTGS2—blood vessel—melanoma	0.0011	0.0693	CbGeAlD
Oxaprozin—Pancytopenia—Dactinomycin—melanoma	0.0011	0.00489	CcSEcCtD
Oxaprozin—Acute coronary syndrome—Bleomycin—melanoma	0.00109	0.00485	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00109	0.00485	CcSEcCtD
Oxaprozin—Hypotension—Vemurafenib—melanoma	0.00109	0.00484	CcSEcCtD
Oxaprozin—Myocardial infarction—Bleomycin—melanoma	0.00108	0.00482	CcSEcCtD
Oxaprozin—Stomatitis—Bleomycin—melanoma	0.00108	0.0048	CcSEcCtD
Oxaprozin—Haematuria—Bleomycin—melanoma	0.00105	0.00469	CcSEcCtD
Oxaprozin—Pneumonia—Dactinomycin—melanoma	0.00104	0.00462	CcSEcCtD
Oxaprozin—Pancytopenia—Carmustine—melanoma	0.00103	0.00458	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00102	0.00455	CcSEcCtD
Oxaprozin—Sweating increased—Temozolomide—melanoma	0.00102	0.00454	CcSEcCtD
Oxaprozin—Oesophagitis—Docetaxel—melanoma	0.00101	0.00451	CcSEcCtD
Oxaprozin—Decreased appetite—Vemurafenib—melanoma	0.00101	0.0045	CcSEcCtD
Oxaprozin—Stomatitis—Dactinomycin—melanoma	0.001	0.00447	CcSEcCtD
Oxaprozin—Haemoglobin—Bleomycin—melanoma	0.000997	0.00444	CcSEcCtD
Oxaprozin—Constipation—Vemurafenib—melanoma	0.000994	0.00443	CcSEcCtD
Oxaprozin—Pancytopenia—Temozolomide—melanoma	0.000992	0.00442	CcSEcCtD
Oxaprozin—Haemorrhage—Bleomycin—melanoma	0.000992	0.00442	CcSEcCtD
Oxaprozin—Dysuria—Temozolomide—melanoma	0.000977	0.00435	CcSEcCtD
Oxaprozin—Hyperglycaemia—Carmustine—melanoma	0.000976	0.00435	CcSEcCtD
Oxaprozin—Pneumonia—Carmustine—melanoma	0.00097	0.00432	CcSEcCtD
Oxaprozin—Agranulocytosis—Dactinomycin—melanoma	0.000961	0.00428	CcSEcCtD
Oxaprozin—Sepsis—Docetaxel—melanoma	0.000961	0.00428	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Temozolomide—melanoma	0.000954	0.00425	CcSEcCtD
Oxaprozin—Renal failure—Carmustine—melanoma	0.000948	0.00422	CcSEcCtD
Oxaprozin—Hyperglycaemia—Temozolomide—melanoma	0.000943	0.0042	CcSEcCtD
Oxaprozin—Stomatitis—Carmustine—melanoma	0.00094	0.00419	CcSEcCtD
Oxaprozin—Pneumonia—Temozolomide—melanoma	0.000937	0.00418	CcSEcCtD
Oxaprozin—Hepatitis—Dactinomycin—melanoma	0.000925	0.00412	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000924	0.00412	CcSEcCtD
Oxaprozin—Body temperature increased—Vemurafenib—melanoma	0.000919	0.0041	CcSEcCtD
Oxaprozin—Stomatitis—Temozolomide—melanoma	0.000908	0.00405	CcSEcCtD
Oxaprozin—Deafness—Docetaxel—melanoma	0.000899	0.004	CcSEcCtD
Oxaprozin—Hepatic failure—Docetaxel—melanoma	0.000895	0.00399	CcSEcCtD
Oxaprozin—Cardiac failure congestive—Docetaxel—melanoma	0.000887	0.00395	CcSEcCtD
Oxaprozin—Alopecia—Bleomycin—melanoma	0.000876	0.0039	CcSEcCtD
Oxaprozin—Erythema multiforme—Dactinomycin—melanoma	0.000874	0.0039	CcSEcCtD
Oxaprozin—Sinusitis—Temozolomide—melanoma	0.000874	0.00389	CcSEcCtD
Oxaprozin—Haemoglobin—Carmustine—melanoma	0.00087	0.00388	CcSEcCtD
Oxaprozin—Haemorrhage—Carmustine—melanoma	0.000866	0.00386	CcSEcCtD
Oxaprozin—Hallucination—Carmustine—melanoma	0.000861	0.00384	CcSEcCtD
Oxaprozin—Renal impairment—Docetaxel—melanoma	0.000845	0.00376	CcSEcCtD
Oxaprozin—Haemoglobin—Temozolomide—melanoma	0.000841	0.00375	CcSEcCtD
Oxaprozin—Hepatitis—Temozolomide—melanoma	0.000836	0.00373	CcSEcCtD
Oxaprozin—Haemorrhage—Temozolomide—melanoma	0.000836	0.00373	CcSEcCtD
Oxaprozin—Asthenia—Vemurafenib—melanoma	0.000834	0.00372	CcSEcCtD
Oxaprozin—Hallucination—Temozolomide—melanoma	0.000832	0.00371	CcSEcCtD
Oxaprozin—Pruritus—Vemurafenib—melanoma	0.000823	0.00367	CcSEcCtD
Oxaprozin—Lethargy—Docetaxel—melanoma	0.000821	0.00366	CcSEcCtD
Oxaprozin—Alopecia—Dactinomycin—melanoma	0.000817	0.00364	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000804	0.00358	CcSEcCtD
Oxaprozin—Ill-defined disorder—Bleomycin—melanoma	0.000801	0.00357	CcSEcCtD
Oxaprozin—Anaemia—Bleomycin—melanoma	0.000798	0.00355	CcSEcCtD
Oxaprozin—Diarrhoea—Vemurafenib—melanoma	0.000796	0.00354	CcSEcCtD
Oxaprozin—Erythema multiforme—Temozolomide—melanoma	0.000791	0.00352	CcSEcCtD
Oxaprozin—Tinnitus—Temozolomide—melanoma	0.00078	0.00347	CcSEcCtD
Oxaprozin—Malaise—Bleomycin—melanoma	0.000778	0.00347	CcSEcCtD
Oxaprozin—Arrhythmia—Carmustine—melanoma	0.000773	0.00345	CcSEcCtD
Oxaprozin—Leukopenia—Bleomycin—melanoma	0.000773	0.00344	CcSEcCtD
Oxaprozin—Dizziness—Vemurafenib—melanoma	0.000769	0.00343	CcSEcCtD
Oxaprozin—Alopecia—Carmustine—melanoma	0.000765	0.00341	CcSEcCtD
Oxaprozin—Ill-defined disorder—Dactinomycin—melanoma	0.000747	0.00333	CcSEcCtD
Oxaprozin—Anaemia—Dactinomycin—melanoma	0.000744	0.00332	CcSEcCtD
Oxaprozin—Vomiting—Vemurafenib—melanoma	0.000739	0.00329	CcSEcCtD
Oxaprozin—Alopecia—Temozolomide—melanoma	0.000739	0.00329	CcSEcCtD
Oxaprozin—Abdominal pain upper—Docetaxel—melanoma	0.000734	0.00327	CcSEcCtD
Oxaprozin—Rash—Vemurafenib—melanoma	0.000733	0.00327	CcSEcCtD
Oxaprozin—Dermatitis—Vemurafenib—melanoma	0.000733	0.00326	CcSEcCtD
Oxaprozin—Headache—Vemurafenib—melanoma	0.000728	0.00325	CcSEcCtD
Oxaprozin—Discomfort—Bleomycin—melanoma	0.000726	0.00323	CcSEcCtD
Oxaprozin—Malaise—Dactinomycin—melanoma	0.000726	0.00323	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000724	0.00323	CcSEcCtD
Oxaprozin—Leukopenia—Dactinomycin—melanoma	0.000721	0.00321	CcSEcCtD
Oxaprozin—Dysgeusia—Temozolomide—melanoma	0.000713	0.00318	CcSEcCtD
Oxaprozin—Confusional state—Bleomycin—melanoma	0.00071	0.00316	CcSEcCtD
Oxaprozin—Vision blurred—Carmustine—melanoma	0.00071	0.00316	CcSEcCtD
Oxaprozin—Tremor—Carmustine—melanoma	0.000706	0.00315	CcSEcCtD
Oxaprozin—Anaphylactic shock—Bleomycin—melanoma	0.000705	0.00314	CcSEcCtD
Oxaprozin—Oedema—Bleomycin—melanoma	0.000705	0.00314	CcSEcCtD
Oxaprozin—Infection—Bleomycin—melanoma	0.0007	0.00312	CcSEcCtD
Oxaprozin—Anaemia—Carmustine—melanoma	0.000696	0.0031	CcSEcCtD
Oxaprozin—Nausea—Vemurafenib—melanoma	0.000691	0.00308	CcSEcCtD
Oxaprozin—Thrombocytopenia—Bleomycin—melanoma	0.00069	0.00307	CcSEcCtD
Oxaprozin—Vision blurred—Temozolomide—melanoma	0.000686	0.00306	CcSEcCtD
Oxaprozin—Tremor—Temozolomide—melanoma	0.000682	0.00304	CcSEcCtD
Oxaprozin—Discomfort—Dactinomycin—melanoma	0.000677	0.00302	CcSEcCtD
Oxaprozin—Ill-defined disorder—Temozolomide—melanoma	0.000676	0.00301	CcSEcCtD
Oxaprozin—Leukopenia—Carmustine—melanoma	0.000674	0.003	CcSEcCtD
Oxaprozin—Anaemia—Temozolomide—melanoma	0.000673	0.003	CcSEcCtD
Oxaprozin—Anorexia—Bleomycin—melanoma	0.000672	0.00299	CcSEcCtD
Oxaprozin—Angioedema—Temozolomide—melanoma	0.000665	0.00296	CcSEcCtD
Oxaprozin—Pancytopenia—Docetaxel—melanoma	0.00066	0.00294	CcSEcCtD
Oxaprozin—Hypotension—Bleomycin—melanoma	0.000658	0.00293	CcSEcCtD
Oxaprozin—Oedema—Dactinomycin—melanoma	0.000657	0.00293	CcSEcCtD
Oxaprozin—Malaise—Temozolomide—melanoma	0.000657	0.00293	CcSEcCtD
Oxaprozin—Vertigo—Temozolomide—melanoma	0.000654	0.00291	CcSEcCtD
Oxaprozin—Convulsion—Carmustine—melanoma	0.000653	0.00291	CcSEcCtD
Oxaprozin—Infection—Dactinomycin—melanoma	0.000653	0.00291	CcSEcCtD
Oxaprozin—Leukopenia—Temozolomide—melanoma	0.000652	0.0029	CcSEcCtD
Oxaprozin—Hypertension—Carmustine—melanoma	0.000651	0.0029	CcSEcCtD
Oxaprozin—Palpitations—Temozolomide—melanoma	0.000643	0.00287	CcSEcCtD
Oxaprozin—Thrombocytopenia—Dactinomycin—melanoma	0.000643	0.00287	CcSEcCtD
Oxaprozin—Anxiety—Carmustine—melanoma	0.000639	0.00285	CcSEcCtD
Oxaprozin—Paraesthesia—Bleomycin—melanoma	0.000633	0.00282	CcSEcCtD
Oxaprozin—Convulsion—Temozolomide—melanoma	0.000631	0.00281	CcSEcCtD
Oxaprozin—Hypertension—Temozolomide—melanoma	0.000629	0.0028	CcSEcCtD
Oxaprozin—Dyspnoea—Bleomycin—melanoma	0.000628	0.0028	CcSEcCtD
Oxaprozin—Anorexia—Dactinomycin—melanoma	0.000626	0.00279	CcSEcCtD
Oxaprozin—Pneumonia—Docetaxel—melanoma	0.000623	0.00278	CcSEcCtD
Oxaprozin—Confusional state—Carmustine—melanoma	0.00062	0.00276	CcSEcCtD
Oxaprozin—Anxiety—Temozolomide—melanoma	0.000618	0.00275	CcSEcCtD
Oxaprozin—Oedema—Carmustine—melanoma	0.000615	0.00274	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000614	0.00274	CcSEcCtD
Oxaprozin—Discomfort—Temozolomide—melanoma	0.000613	0.00273	CcSEcCtD
Oxaprozin—Decreased appetite—Bleomycin—melanoma	0.000612	0.00273	CcSEcCtD
Oxaprozin—Infection—Carmustine—melanoma	0.000611	0.00272	CcSEcCtD
Oxaprozin—Acute coronary syndrome—Docetaxel—melanoma	0.000611	0.00272	CcSEcCtD
Oxaprozin—Renal failure—Docetaxel—melanoma	0.000609	0.00271	CcSEcCtD
Oxaprozin—Myocardial infarction—Docetaxel—melanoma	0.000607	0.00271	CcSEcCtD
Oxaprozin—Dry mouth—Temozolomide—melanoma	0.000606	0.0027	CcSEcCtD
Oxaprozin—Jaundice—Docetaxel—melanoma	0.000604	0.00269	CcSEcCtD
Oxaprozin—Stomatitis—Docetaxel—melanoma	0.000604	0.00269	CcSEcCtD
Oxaprozin—Conjunctivitis—Docetaxel—melanoma	0.000602	0.00268	CcSEcCtD
Oxaprozin—Thrombocytopenia—Carmustine—melanoma	0.000602	0.00268	CcSEcCtD
Oxaprozin—Tachycardia—Carmustine—melanoma	0.0006	0.00267	CcSEcCtD
Oxaprozin—Confusional state—Temozolomide—melanoma	0.000599	0.00267	CcSEcCtD
Oxaprozin—Fenbufen—PTGS2—melanoma	0.000596	0.122	CrCbGaD
Oxaprozin—Anaphylactic shock—Temozolomide—melanoma	0.000594	0.00265	CcSEcCtD
Oxaprozin—Oedema—Temozolomide—melanoma	0.000594	0.00265	CcSEcCtD
Oxaprozin—Infection—Temozolomide—melanoma	0.00059	0.00263	CcSEcCtD
Oxaprozin—Anorexia—Carmustine—melanoma	0.000586	0.00261	CcSEcCtD
Oxaprozin—Thrombocytopenia—Temozolomide—melanoma	0.000582	0.00259	CcSEcCtD
Oxaprozin—Feeling abnormal—Bleomycin—melanoma	0.000581	0.00259	CcSEcCtD
Oxaprozin—Agranulocytosis—Docetaxel—melanoma	0.000578	0.00258	CcSEcCtD
Oxaprozin—Hypotension—Carmustine—melanoma	0.000575	0.00256	CcSEcCtD
Oxaprozin—Hyperhidrosis—Temozolomide—melanoma	0.000575	0.00256	CcSEcCtD
Oxaprozin—Decreased appetite—Dactinomycin—melanoma	0.000571	0.00254	CcSEcCtD
Oxaprozin—Anorexia—Temozolomide—melanoma	0.000566	0.00252	CcSEcCtD
Oxaprozin—Urticaria—Bleomycin—melanoma	0.00056	0.00249	CcSEcCtD
Oxaprozin—Haemoglobin—Docetaxel—melanoma	0.000559	0.00249	CcSEcCtD
Oxaprozin—Body temperature increased—Bleomycin—melanoma	0.000557	0.00248	CcSEcCtD
Oxaprozin—Hepatitis—Docetaxel—melanoma	0.000556	0.00248	CcSEcCtD
Oxaprozin—Haemorrhage—Docetaxel—melanoma	0.000556	0.00248	CcSEcCtD
Oxaprozin—Insomnia—Carmustine—melanoma	0.000556	0.00248	CcSEcCtD
Oxaprozin—Paraesthesia—Carmustine—melanoma	0.000552	0.00246	CcSEcCtD
Oxaprozin—Dyspnoea—Carmustine—melanoma	0.000548	0.00244	CcSEcCtD
Oxaprozin—Somnolence—Carmustine—melanoma	0.000547	0.00244	CcSEcCtD
Oxaprozin—Feeling abnormal—Dactinomycin—melanoma	0.000541	0.00241	CcSEcCtD
Oxaprozin—Insomnia—Temozolomide—melanoma	0.000538	0.00239	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Dactinomycin—melanoma	0.000537	0.00239	CcSEcCtD
Oxaprozin—Decreased appetite—Carmustine—melanoma	0.000535	0.00238	CcSEcCtD
Oxaprozin—Paraesthesia—Temozolomide—melanoma	0.000534	0.00238	CcSEcCtD
Oxaprozin—PTGS1—skin of body—melanoma	0.000532	0.0335	CbGeAlD
Oxaprozin—Dyspnoea—Temozolomide—melanoma	0.00053	0.00236	CcSEcCtD
Oxaprozin—Somnolence—Temozolomide—melanoma	0.000528	0.00235	CcSEcCtD
Oxaprozin—Erythema multiforme—Docetaxel—melanoma	0.000526	0.00234	CcSEcCtD
Oxaprozin—Constipation—Carmustine—melanoma	0.000526	0.00234	CcSEcCtD
Oxaprozin—Dyspepsia—Temozolomide—melanoma	0.000523	0.00233	CcSEcCtD
Oxaprozin—Abdominal pain—Dactinomycin—melanoma	0.000519	0.00231	CcSEcCtD
Oxaprozin—Body temperature increased—Dactinomycin—melanoma	0.000519	0.00231	CcSEcCtD
Oxaprozin—Decreased appetite—Temozolomide—melanoma	0.000517	0.0023	CcSEcCtD
Oxaprozin—PTGS2—skin of body—melanoma	0.000509	0.0321	CbGeAlD
Oxaprozin—Constipation—Temozolomide—melanoma	0.000508	0.00226	CcSEcCtD
Oxaprozin—Feeling abnormal—Carmustine—melanoma	0.000507	0.00226	CcSEcCtD
Oxaprozin—Asthenia—Bleomycin—melanoma	0.000505	0.00225	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Carmustine—melanoma	0.000503	0.00224	CcSEcCtD
Oxaprozin—Pruritus—Bleomycin—melanoma	0.000498	0.00222	CcSEcCtD
Oxaprozin—Arrhythmia—Docetaxel—melanoma	0.000497	0.00221	CcSEcCtD
Oxaprozin—Alopecia—Docetaxel—melanoma	0.000492	0.00219	CcSEcCtD
Oxaprozin—Feeling abnormal—Temozolomide—melanoma	0.00049	0.00218	CcSEcCtD
Oxaprozin—Body temperature increased—Carmustine—melanoma	0.000486	0.00217	CcSEcCtD
Oxaprozin—Abdominal pain—Carmustine—melanoma	0.000486	0.00217	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Temozolomide—melanoma	0.000486	0.00217	CcSEcCtD
Oxaprozin—PTGS1—mammalian vulva—melanoma	0.000485	0.0306	CbGeAlD
Oxaprozin—Dysgeusia—Docetaxel—melanoma	0.000474	0.00211	CcSEcCtD
Oxaprozin—Urticaria—Temozolomide—melanoma	0.000472	0.0021	CcSEcCtD
Oxaprozin—Asthenia—Dactinomycin—melanoma	0.000471	0.0021	CcSEcCtD
Oxaprozin—Body temperature increased—Temozolomide—melanoma	0.00047	0.00209	CcSEcCtD
Oxaprozin—Abdominal pain—Temozolomide—melanoma	0.00047	0.00209	CcSEcCtD
Oxaprozin—Diarrhoea—Dactinomycin—melanoma	0.00045	0.002	CcSEcCtD
Oxaprozin—Vomiting—Bleomycin—melanoma	0.000448	0.002	CcSEcCtD
Oxaprozin—Anaemia—Docetaxel—melanoma	0.000448	0.00199	CcSEcCtD
Oxaprozin—Rash—Bleomycin—melanoma	0.000444	0.00198	CcSEcCtD
Oxaprozin—Dermatitis—Bleomycin—melanoma	0.000444	0.00198	CcSEcCtD
Oxaprozin—Asthenia—Carmustine—melanoma	0.000441	0.00197	CcSEcCtD
Oxaprozin—Syncope—Docetaxel—melanoma	0.000434	0.00193	CcSEcCtD
Oxaprozin—Leukopenia—Docetaxel—melanoma	0.000433	0.00193	CcSEcCtD
Oxaprozin—Palpitations—Docetaxel—melanoma	0.000428	0.00191	CcSEcCtD
Oxaprozin—Asthenia—Temozolomide—melanoma	0.000426	0.0019	CcSEcCtD
Oxaprozin—Loss of consciousness—Docetaxel—melanoma	0.000426	0.0019	CcSEcCtD
Oxaprozin—Diarrhoea—Carmustine—melanoma	0.000421	0.00187	CcSEcCtD
Oxaprozin—Pruritus—Temozolomide—melanoma	0.00042	0.00187	CcSEcCtD
Oxaprozin—Convulsion—Docetaxel—melanoma	0.00042	0.00187	CcSEcCtD
Oxaprozin—Nausea—Bleomycin—melanoma	0.000418	0.00186	CcSEcCtD
Oxaprozin—Hypertension—Docetaxel—melanoma	0.000418	0.00186	CcSEcCtD
Oxaprozin—Vomiting—Dactinomycin—melanoma	0.000418	0.00186	CcSEcCtD
Oxaprozin—Rash—Dactinomycin—melanoma	0.000414	0.00185	CcSEcCtD
Oxaprozin—Dizziness—Carmustine—melanoma	0.000407	0.00181	CcSEcCtD
Oxaprozin—Diarrhoea—Temozolomide—melanoma	0.000407	0.00181	CcSEcCtD
Oxaprozin—Dry mouth—Docetaxel—melanoma	0.000403	0.0018	CcSEcCtD
Oxaprozin—Confusional state—Docetaxel—melanoma	0.000398	0.00178	CcSEcCtD
Oxaprozin—Oedema—Docetaxel—melanoma	0.000395	0.00176	CcSEcCtD
Oxaprozin—Anaphylactic shock—Docetaxel—melanoma	0.000395	0.00176	CcSEcCtD
Oxaprozin—Dizziness—Temozolomide—melanoma	0.000393	0.00175	CcSEcCtD
Oxaprozin—Infection—Docetaxel—melanoma	0.000393	0.00175	CcSEcCtD
Oxaprozin—Vomiting—Carmustine—melanoma	0.000391	0.00174	CcSEcCtD
Oxaprozin—Nausea—Dactinomycin—melanoma	0.00039	0.00174	CcSEcCtD
Oxaprozin—Shock—Docetaxel—melanoma	0.000389	0.00173	CcSEcCtD
Oxaprozin—Rash—Carmustine—melanoma	0.000388	0.00173	CcSEcCtD
Oxaprozin—Dermatitis—Carmustine—melanoma	0.000387	0.00173	CcSEcCtD
Oxaprozin—Thrombocytopenia—Docetaxel—melanoma	0.000387	0.00172	CcSEcCtD
Oxaprozin—Tachycardia—Docetaxel—melanoma	0.000386	0.00172	CcSEcCtD
Oxaprozin—Headache—Carmustine—melanoma	0.000385	0.00172	CcSEcCtD
Oxaprozin—Vomiting—Temozolomide—melanoma	0.000378	0.00168	CcSEcCtD
Oxaprozin—Anorexia—Docetaxel—melanoma	0.000377	0.00168	CcSEcCtD
Oxaprozin—Rash—Temozolomide—melanoma	0.000375	0.00167	CcSEcCtD
Oxaprozin—Dermatitis—Temozolomide—melanoma	0.000374	0.00167	CcSEcCtD
Oxaprozin—Headache—Temozolomide—melanoma	0.000372	0.00166	CcSEcCtD
Oxaprozin—Hypotension—Docetaxel—melanoma	0.000369	0.00165	CcSEcCtD
Oxaprozin—Nausea—Carmustine—melanoma	0.000365	0.00163	CcSEcCtD
Oxaprozin—Insomnia—Docetaxel—melanoma	0.000357	0.00159	CcSEcCtD
Oxaprozin—Paraesthesia—Docetaxel—melanoma	0.000355	0.00158	CcSEcCtD
Oxaprozin—Nausea—Temozolomide—melanoma	0.000353	0.00157	CcSEcCtD
Oxaprozin—Dyspnoea—Docetaxel—melanoma	0.000352	0.00157	CcSEcCtD
Oxaprozin—Somnolence—Docetaxel—melanoma	0.000351	0.00157	CcSEcCtD
Oxaprozin—Dyspepsia—Docetaxel—melanoma	0.000348	0.00155	CcSEcCtD
Oxaprozin—PTGS1—head—melanoma	0.000347	0.0219	CbGeAlD
Oxaprozin—Decreased appetite—Docetaxel—melanoma	0.000344	0.00153	CcSEcCtD
Oxaprozin—Phenylbutazone—PTGS2—melanoma	0.000342	0.0702	CrCbGaD
Oxaprozin—Constipation—Docetaxel—melanoma	0.000338	0.00151	CcSEcCtD
Oxaprozin—PTGS2—head—melanoma	0.000332	0.0209	CbGeAlD
Oxaprozin—Phenprocoumon—ALB—melanoma	0.000329	0.0674	CrCbGaD
Oxaprozin—Feeling abnormal—Docetaxel—melanoma	0.000326	0.00145	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Docetaxel—melanoma	0.000323	0.00144	CcSEcCtD
Oxaprozin—Body temperature increased—Docetaxel—melanoma	0.000312	0.00139	CcSEcCtD
Oxaprozin—Abdominal pain—Docetaxel—melanoma	0.000312	0.00139	CcSEcCtD
Oxaprozin—Warfarin—ALB—melanoma	0.000292	0.0598	CrCbGaD
Oxaprozin—Asthenia—Docetaxel—melanoma	0.000284	0.00126	CcSEcCtD
Oxaprozin—Pruritus—Docetaxel—melanoma	0.00028	0.00125	CcSEcCtD
Oxaprozin—Flurbiprofen—PTGS2—melanoma	0.000279	0.0572	CrCbGaD
Oxaprozin—Propafenone—ABCB1—melanoma	0.000272	0.0558	CrCbGaD
Oxaprozin—Diarrhoea—Docetaxel—melanoma	0.00027	0.0012	CcSEcCtD
Oxaprozin—Dizziness—Docetaxel—melanoma	0.000261	0.00116	CcSEcCtD
Oxaprozin—Vomiting—Docetaxel—melanoma	0.000251	0.00112	CcSEcCtD
Oxaprozin—Rash—Docetaxel—melanoma	0.000249	0.00111	CcSEcCtD
Oxaprozin—Dermatitis—Docetaxel—melanoma	0.000249	0.00111	CcSEcCtD
Oxaprozin—Flurbiprofen—ALB—melanoma	0.000249	0.051	CrCbGaD
Oxaprozin—Headache—Docetaxel—melanoma	0.000248	0.0011	CcSEcCtD
Oxaprozin—PTGS1—lymph node—melanoma	0.000243	0.0153	CbGeAlD
Oxaprozin—Nausea—Docetaxel—melanoma	0.000235	0.00105	CcSEcCtD
Oxaprozin—PTGS2—lymph node—melanoma	0.000232	0.0147	CbGeAlD
Oxaprozin—Phenytoin—ALB—melanoma	0.000212	0.0434	CrCbGaD
Oxaprozin—Carbamazepine—ABCB1—melanoma	0.000208	0.0427	CrCbGaD
Oxaprozin—Phenytoin—ABCB1—melanoma	0.000202	0.0415	CrCbGaD
Oxaprozin—Methadone—ABCB1—melanoma	0.000153	0.0313	CrCbGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—NRAS—melanoma	8.22e-05	0.00143	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	8.11e-05	0.00141	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—UGT2B10—melanoma	8.06e-05	0.0014	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	7.95e-05	0.00138	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	7.94e-05	0.00138	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CXCL8—melanoma	7.81e-05	0.00136	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—melanoma	7.7e-05	0.00134	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	7.66e-05	0.00133	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—MYC—melanoma	7.66e-05	0.00133	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CDKN1B—melanoma	7.62e-05	0.00133	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	7.59e-05	0.00132	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HS3ST5—melanoma	7.49e-05	0.0013	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CASP3—melanoma	7.47e-05	0.0013	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL2—melanoma	7.46e-05	0.0013	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CCND1—melanoma	7.27e-05	0.00126	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—melanoma	7.21e-05	0.00125	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PLCB4—melanoma	7.15e-05	0.00124	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—melanoma	7.13e-05	0.00124	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—KRAS—melanoma	7.08e-05	0.00123	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MMP9—melanoma	7.06e-05	0.00123	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—FASN—melanoma	7.02e-05	0.00122	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IL6—melanoma	6.99e-05	0.00121	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—TNF—melanoma	6.87e-05	0.00119	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC6A11—melanoma	6.72e-05	0.00117	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIP4K2A—melanoma	6.72e-05	0.00117	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	6.72e-05	0.00117	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	6.62e-05	0.00115	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	6.6e-05	0.00115	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MTAP—melanoma	6.54e-05	0.00114	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	6.39e-05	0.00111	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	6.38e-05	0.00111	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CUL3—melanoma	6.37e-05	0.00111	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TRRAP—melanoma	6.37e-05	0.00111	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKR1B10—melanoma	6.2e-05	0.00108	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	6.2e-05	0.00108	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	6.07e-05	0.00106	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	6.03e-05	0.00105	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—HRAS—melanoma	6.01e-05	0.00105	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MAPK3—melanoma	6e-05	0.00104	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MYC—melanoma	5.83e-05	0.00101	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ACER3—melanoma	5.83e-05	0.00101	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PHGDH—melanoma	5.83e-05	0.00101	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—LUM—melanoma	5.83e-05	0.00101	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	5.77e-05	0.001	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—HPSE—melanoma	5.72e-05	0.000994	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MAPK1—melanoma	5.71e-05	0.000992	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—EGFR—melanoma	5.71e-05	0.000992	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	5.68e-05	0.000988	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PLCB4—melanoma	5.68e-05	0.000987	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CUBN—melanoma	5.61e-05	0.000975	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	5.6e-05	0.000974	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—FASN—melanoma	5.57e-05	0.000968	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IL6—melanoma	5.55e-05	0.000964	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—LUM—melanoma	5.53e-05	0.00096	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TNF—melanoma	5.43e-05	0.000945	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CSPG4—melanoma	5.42e-05	0.000942	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—BSG—melanoma	5.42e-05	0.000942	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SDHD—melanoma	5.42e-05	0.000942	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HPSE—melanoma	5.42e-05	0.000942	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC6A11—melanoma	5.34e-05	0.000928	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIP4K2A—melanoma	5.34e-05	0.000928	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—UGT2B10—melanoma	5.34e-05	0.000927	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CUBN—melanoma	5.32e-05	0.000925	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	5.27e-05	0.000916	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GPAM—melanoma	5.25e-05	0.000912	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MTAP—melanoma	5.19e-05	0.000902	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	5.19e-05	0.000902	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CSPG4—melanoma	5.14e-05	0.000893	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	5.08e-05	0.000884	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	5.07e-05	0.000882	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RPS3—melanoma	5.05e-05	0.000878	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SKI—melanoma	4.97e-05	0.000865	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HS3ST5—melanoma	4.96e-05	0.000862	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	4.95e-05	0.00086	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	4.9e-05	0.000852	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TP53—melanoma	4.79e-05	0.000833	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	4.79e-05	0.000832	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	4.78e-05	0.00083	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	4.75e-05	0.000826	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PHGDH—melanoma	4.63e-05	0.000804	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—LUM—melanoma	4.63e-05	0.000804	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HPSE—melanoma	4.54e-05	0.000789	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PLA2G6—melanoma	4.46e-05	0.000776	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CUBN—melanoma	4.45e-05	0.000774	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL6—melanoma	4.39e-05	0.000762	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	4.31e-05	0.00075	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SDHD—melanoma	4.3e-05	0.000748	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—BSG—melanoma	4.3e-05	0.000748	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CSPG4—melanoma	4.3e-05	0.000748	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GPAM—melanoma	4.17e-05	0.000724	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HDAC6—melanoma	4.11e-05	0.000714	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	4.08e-05	0.000709	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—VCAN—melanoma	4.01e-05	0.000697	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.99e-05	0.000694	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.97e-05	0.00069	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NPPA—melanoma	3.89e-05	0.000677	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.88e-05	0.000675	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.88e-05	0.000675	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—VCAN—melanoma	3.8e-05	0.00066	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.79e-05	0.00066	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—WNT5A—melanoma	3.77e-05	0.000655	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PLCB4—melanoma	3.76e-05	0.000653	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.7e-05	0.000643	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	3.69e-05	0.000641	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	3.67e-05	0.000638	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.66e-05	0.000637	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PLA2G6—melanoma	3.54e-05	0.000616	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC6A11—melanoma	3.53e-05	0.000614	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIP4K2A—melanoma	3.53e-05	0.000614	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTAP—melanoma	3.44e-05	0.000598	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP17A1—melanoma	3.38e-05	0.000588	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.37e-05	0.000586	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.36e-05	0.000584	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.34e-05	0.00058	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	3.29e-05	0.000572	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.26e-05	0.000567	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GNA11—melanoma	3.19e-05	0.000555	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—VCAN—melanoma	3.18e-05	0.000553	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—FASN—melanoma	3.13e-05	0.000543	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC5A5—melanoma	3.07e-05	0.000534	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PHGDH—melanoma	3.06e-05	0.000533	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LUM—melanoma	3.06e-05	0.000533	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—GAB2—melanoma	3.03e-05	0.000526	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.01e-05	0.000524	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HPSE—melanoma	3.01e-05	0.000522	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GNAQ—melanoma	2.97e-05	0.000516	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CD44—melanoma	2.97e-05	0.000516	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FASN—melanoma	2.96e-05	0.000515	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CUBN—melanoma	2.95e-05	0.000513	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.91e-05	0.000505	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.91e-05	0.000505	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.88e-05	0.000501	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SDHD—melanoma	2.85e-05	0.000495	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CSPG4—melanoma	2.85e-05	0.000495	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—BSG—melanoma	2.85e-05	0.000495	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP1B1—melanoma	2.85e-05	0.000495	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HDAC2—melanoma	2.85e-05	0.000495	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CXCR4—melanoma	2.85e-05	0.000495	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FOXO4—melanoma	2.85e-05	0.000495	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD44—melanoma	2.81e-05	0.000489	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GPAM—melanoma	2.76e-05	0.00048	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.75e-05	0.000478	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP17A1—melanoma	2.68e-05	0.000467	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.65e-05	0.00046	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.61e-05	0.000454	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKT3—melanoma	2.6e-05	0.000452	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GNA11—melanoma	2.54e-05	0.000441	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.51e-05	0.000437	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—FASN—melanoma	2.48e-05	0.000431	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC5A5—melanoma	2.44e-05	0.000424	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GNAQ—melanoma	2.36e-05	0.00041	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CD44—melanoma	2.36e-05	0.00041	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PLA2G6—melanoma	2.35e-05	0.000408	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ABCB1—melanoma	2.34e-05	0.000407	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.31e-05	0.000401	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERBB4—melanoma	2.29e-05	0.000399	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN2B—melanoma	2.27e-05	0.000395	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP1B1—melanoma	2.26e-05	0.000393	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD86—melanoma	2.2e-05	0.000382	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PRKCA—melanoma	2.16e-05	0.000375	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ERCC2—melanoma	2.14e-05	0.000372	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF1—melanoma	2.13e-05	0.000371	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—VCAN—melanoma	2.11e-05	0.000366	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PDGFRA—melanoma	2.07e-05	0.000359	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PRKCA—melanoma	2.04e-05	0.000355	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERCC2—melanoma	2.03e-05	0.000353	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAP2K2—melanoma	2e-05	0.000348	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.99e-05	0.000347	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.99e-05	0.000347	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.93e-05	0.000335	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TERT—melanoma	1.9e-05	0.00033	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HLA-A—melanoma	1.9e-05	0.00033	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RAC1—melanoma	1.9e-05	0.00033	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCB1—melanoma	1.86e-05	0.000323	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HIF1A—melanoma	1.82e-05	0.000316	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP17A1—melanoma	1.78e-05	0.000309	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.77e-05	0.000308	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.75e-05	0.000305	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.73e-05	0.000301	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PRKCA—melanoma	1.71e-05	0.000298	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ERCC2—melanoma	1.7e-05	0.000295	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CG—melanoma	1.69e-05	0.000294	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GNA11—melanoma	1.68e-05	0.000292	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NOS2—melanoma	1.65e-05	0.000287	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—FASN—melanoma	1.64e-05	0.000286	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NOTCH1—melanoma	1.64e-05	0.000285	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PPARG—melanoma	1.63e-05	0.000283	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC5A5—melanoma	1.62e-05	0.000281	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD80—melanoma	1.6e-05	0.000279	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KIT—melanoma	1.6e-05	0.000278	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APC—melanoma	1.6e-05	0.000278	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EGF—melanoma	1.58e-05	0.000275	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CD44—melanoma	1.56e-05	0.000271	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GNAQ—melanoma	1.56e-05	0.000271	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.53e-05	0.000266	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.51e-05	0.000263	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—BRAF—melanoma	1.51e-05	0.000262	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP1B1—melanoma	1.5e-05	0.00026	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CD—melanoma	1.49e-05	0.000258	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALB—melanoma	1.47e-05	0.000255	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAP2K1—melanoma	1.42e-05	0.000246	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CD—melanoma	1.41e-05	0.000245	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.41e-05	0.000245	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF2—melanoma	1.35e-05	0.000234	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CG—melanoma	1.34e-05	0.000233	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.32e-05	0.00023	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CB—melanoma	1.29e-05	0.000225	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PPARG—melanoma	1.29e-05	0.000225	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTGS2—melanoma	1.28e-05	0.000223	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MDM2—melanoma	1.26e-05	0.000219	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERBB2—melanoma	1.24e-05	0.000216	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCB1—melanoma	1.23e-05	0.000214	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CB—melanoma	1.23e-05	0.000213	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD4—melanoma	1.23e-05	0.000213	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CD—melanoma	1.18e-05	0.000205	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALB—melanoma	1.16e-05	0.000202	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN1B—melanoma	1.15e-05	0.0002	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PRKCA—melanoma	1.13e-05	0.000197	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ERCC2—melanoma	1.12e-05	0.000196	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTEN—melanoma	1.12e-05	0.000194	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CTNNB1—melanoma	1.09e-05	0.000189	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN1A—melanoma	1.06e-05	0.000185	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PTEN—melanoma	1.06e-05	0.000184	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CB—melanoma	1.03e-05	0.000179	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—STAT3—melanoma	9.49e-06	0.000165	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NRAS—melanoma	9.46e-06	0.000164	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.32e-06	0.000162	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAPK3—melanoma	9.06e-06	0.000158	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CG—melanoma	8.88e-06	0.000154	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PTEN—melanoma	8.88e-06	0.000154	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MYC—melanoma	8.81e-06	0.000153	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAPK1—melanoma	8.62e-06	0.00015	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EGFR—melanoma	8.62e-06	0.00015	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PPARG—melanoma	8.57e-06	0.000149	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KRAS—melanoma	8.14e-06	0.000142	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CA—melanoma	7.89e-06	0.000137	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CD—melanoma	7.81e-06	0.000136	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALB—melanoma	7.71e-06	0.000134	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CA—melanoma	7.48e-06	0.00013	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HRAS—melanoma	6.92e-06	0.00012	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CB—melanoma	6.81e-06	0.000118	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTGS2—melanoma	6.74e-06	0.000117	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6—melanoma	6.63e-06	0.000115	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AKT1—melanoma	6.45e-06	0.000112	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CA—melanoma	6.27e-06	0.000109	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKT1—melanoma	6.11e-06	0.000106	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTEN—melanoma	5.88e-06	0.000102	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AKT1—melanoma	5.12e-06	8.9e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CA—melanoma	4.15e-06	7.21e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AKT1—melanoma	3.39e-06	5.89e-05	CbGpPWpGaD
